Keywords: Epilepsy, Molecular Imaging, therapeutic effectCurrent diagnosis of MRI-negative TLE relies on clinical history and EEG or IEEG. However, IEEG is invasive and fails to monitor therapeutic effects dynamically. It is necessary to screen for effective biomarkers. We used MEGA-PRESS technique to investigate role of GABA and other metabolic alterations in TLE. We demonstrated that GABA, NAA, NAA+NAAG, and Glu levels in MTL were significantly different between epileptic and contralateral sides, and increasing index of GABA values is associated with increasing index of seizure frequency. These findings suggested that GABA is an effective biomarker for lateralization and therapeutic effect monitoring in patients with MRI-negative TLE.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords